Universal-Beteiligungs- und Servicegesellschaft’s Ionis Pharmaceuticals IONS Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.5M	Buy	233,499 +13,847	+6%	+$1.04M	0.03%	436
2026 Q1	$16.5M	Buy	219,652 +78	+0%	+$6.16K	0.03%	448
2025 Q4	$17.4M	Buy	219,574 +22,140	+11%	+$1.67M	0.03%	440
2025 Q3	$12.9M	Buy	197,434 +47,595	+32%	+$2.32M	0.02%	526
2025 Q2	$5.92M	Buy	149,839 +5,969	+4%	+$195K	0.01%	756
2025 Q1	$4.34M	Buy	+143,870	New	+$4.71M	0.01%	858

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's IONS Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Ionis Pharmaceuticals (IONS) stake by 6.3% in Q2 2026, buying an estimated $1.04M and bringing the position to 233,499 shares worth $18.5M. The position accounts for 0.03% of the portfolio, ranked #436.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 233,499 shares of Ionis Pharmaceuticals worth $18.5M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft bought 13,847 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.04M.
Ionis Pharmaceuticals made up 0.03% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #436 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.